Phibro Animal Health Corp... (PAHC)
17.00
0.17 (1.01%)
At close: Apr 17, 2025, 11:32 AM
1.01% (1D)
| Bid | 12.1 |
| Market Cap | 688.56M |
| Revenue (ttm) | 1.11B |
| Net Income (ttm) | 19.32M |
| EPS (ttm) | 0.48 |
| PE Ratio (ttm) | 35.42 |
| Forward PE | 8.7 |
| Analyst | Hold |
| Ask | 21.52 |
| Volume | 46,892 |
| Avg. Volume (20D) | 268,103 |
| Open | 16.93 |
| Previous Close | 16.83 |
| Day's Range | 16.68 - 17.08 |
| 52-Week Range | 12.30 - 26.55 |
| Beta | 0.63 |
About PAHC
Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for livestock primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture. Its animal health products als...
Sector Healthcare
IPO Date Apr 11, 2014
Employees 1,940
Stock Exchange NASDAQ
Ticker Symbol PAHC
Website https://www.pahc.com
Analyst Forecast
According to 4 analyst ratings, the average rating for PAHC stock is "Hold." The 12-month stock price forecast is $22, which is an increase of 29.41% from the latest price.
Stock ForecastsNext Earnings Release
Phibro Animal Health Corporation is scheduled to release its earnings on May 7, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 months ago
+10.68%
Phibro Animal Health shares are trading higher aft...
Unlock content with
Pro Subscription
2 months ago
+9.88%
Phibro Animal Health shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY25 guidance.
